These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1702005)

  • 61. Membrane vesiculation protects erythrocytes from destruction by complement.
    Iida K; Whitlow MB; Nussenzweig V
    J Immunol; 1991 Oct; 147(8):2638-42. PubMed ID: 1918984
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Deposition of terminal C5b-9 complement complexes on erythrocytes and leukocytes during cardiopulmonary bypass.
    Salama A; Hugo F; Heinrich D; Höge R; Müller R; Kiefel V; Mueller-Eckhardt C; Bhakdi S
    N Engl J Med; 1988 Feb; 318(7):408-14. PubMed ID: 3340119
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Discriminating the hemolytic risk of blood type A plasmas using the complement hemolysis using human erythrocytes (CHUHE) assay.
    Cunnion KM; Hair PS; Krishna NK; Sass MA; Enos CW; Whitley PH; Maes LY; Goldberg CL
    Transfusion; 2017 Mar; 57(3):517-524. PubMed ID: 28000304
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Homogeneous chemiluminescent immunoassay based on complement-mediated hemolysis of red blood cells.
    Tatsu Y; Yoshikawa S
    Anal Chem; 1990 Oct; 62(19):2103-6. PubMed ID: 2256546
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Studies of complement-mediated membrane damage: the influence of erythrocyte storage on susceptibility to cytolysis.
    Gaither TA; Frank MM
    J Immunol; 1973 Feb; 110(2):482-9. PubMed ID: 4684035
    [No Abstract]   [Full Text] [Related]  

  • 66. Studies on the antigenic properties of complement. I. Demonstration of agglutinating antibodies against guinea pig complement fixed on sensitized sheep erythrocytes.
    KLEIN PG; BURKHOLDER PM
    J Exp Med; 1960 Jan; 111(1):93-106. PubMed ID: 14409702
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Purification of a human serum protein ("factor E") which enhances cobra venom factor-induced indirect lysis. Identification with the fifth component of complement.
    Lynen R; Vogt W; Schmidt G; Dieminger L
    Z Immunitatsforsch Exp Klin Immunol; 1976 Apr; 151(2):105-16. PubMed ID: 134530
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Elimination of terminal complement complexes in the plasma membrane of nucleated cells: influence of extracellular Ca2+ and association with cellular Ca2+.
    Carney DF; Hammer CH; Shin ML
    J Immunol; 1986 Jul; 137(1):263-70. PubMed ID: 3711667
    [TBL] [Abstract][Full Text] [Related]  

  • 69. COMPONENTS OF GUINEA PIG COMPLEMENT. II. SEPARATION OF SERUM FRACTIONS ESSENTIAL FOR IMMUNE HEMOLYSIS.
    LINSCOTT WD; NISHIOKA K
    J Exp Med; 1963 Nov; 118(5):795-815. PubMed ID: 14087622
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Ultrastructure of anaplasmal inclusions (Pawhuska isolate) and their appendages in intact and hemolyzed erythrocytes and in complement-fixation antigen.
    Kocan KM; Venable JH; Brock WE
    Am J Vet Res; 1978 Jul; 39(7):1123-30. PubMed ID: 677531
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Functional aspects of the vestibular dark cells in the guinea pig: morphological investigation using ruthenium red staining technique.
    Harada Y; Takumida M
    Auris Nasus Larynx; 1990; 17(2):77-85. PubMed ID: 1699515
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Freeze-fracture analysis of the membrane lesion of human complement.
    Tranum-Jensen J; Bhakdi S
    J Cell Biol; 1983 Sep; 97(3):618-26. PubMed ID: 6309866
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Anaphylatoxin in its relation to the complement system.
    Jensen J
    Science; 1967 Mar; 155(3766):1122-3. PubMed ID: 6021911
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Differences in carbohydrate specificities and complement-activating capacity of guinea pig and human antibodies to neuraminidase-treated autologous erythrocytes.
    Lambré CR; Pilatte Y; Le Maho S; Blanc C
    Mol Immunol; 1985 Sep; 22(9):1123-9. PubMed ID: 2415814
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Nucleated cell killing by complement: effects of C5b-9 channel size and extracellular Ca2+ on the lytic process.
    Kim SH; Carney DF; Hammer CH; Shin ML
    J Immunol; 1987 Mar; 138(5):1530-6. PubMed ID: 2433349
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Determination of the number of lytic sites in biconcave and spheroid erythrocyte ghosts after complement lysis.
    Bauer J; Podack ER; Valet G
    J Immunol; 1979 May; 122(5):2032-6. PubMed ID: 448115
    [No Abstract]   [Full Text] [Related]  

  • 77. Vitamin A: probe of immune complement reactions. 3. Inhibition of guinea pig complement hemolysis.
    Westfall SS; Wirtz GH
    Immunochemistry; 1972 May; 9(5):505-12. PubMed ID: 5036148
    [No Abstract]   [Full Text] [Related]  

  • 78. C5b-9 assembly: average binding of one C9 molecule to C5b-8 without poly-C9 formation generates a stable transmembrane pore.
    Bhakdi S; Tranum-Jensen J
    J Immunol; 1986 Apr; 136(8):2999-3005. PubMed ID: 3958488
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The C8-binding protein of human erythrocytes: interaction with the components of the complement-attack phase.
    Schönermark S; Filsinger S; Berger B; Hänsch GM
    Immunology; 1988 Apr; 63(4):585-90. PubMed ID: 3366469
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Anti-immunoglobulin analysis by diffusion patterns of inhibition and facilitation of complementary lysis in agar. I. Diffusion-lysis patterns of heterologous guinea pig anti-immunoglobulins.
    Romeyn JA; Cook J
    J Immunol Methods; 1975 Feb; 6(4):363-73. PubMed ID: 804523
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.